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A genomic clone expressing a Trypanosoma cruzi antigen in Escherichia coli was identified using human
chagasic sera. Chagasic antibodies affinity purified on extracts of this clone recognized a high-molecular-weight
protein expressed in all developmental stages of the parasite life cycle, as well as in various T. cruzi strains. The
antigen is associated with the cytoskeleton of the parasite and localizes along the attachment region between the
flagellum and the cell body. Antibodies to the recombinant antigen were detected in the sera of 115 chagasic
patients from different endemic regions, but not in sera of patients with leishmaniasis, T. rangeli infection, or
other parasitic diseases. Our data suggest that the presence of antibodies to this antigen may be specifically
associated with Chagas' disease.
Trypanosoma cruzi, the etiological agent of Chagas' dis-
ease, displays a complex life cycle, including an invertebrate
triatomine vector and mammalian hosts. During its morpho-
genesis, it displays both stage-specific and common antigens
(1, 19), all part of a complex repertoire that may eventually
be exposed to the host immune system. Recent studies
indicate that this protozoan synthesizes several proteins and
presents a large number of antigenic determinants to the host
immune system (5, 11, 15, 23). The role of these antigens in
the pathogenesis and immunopathology of Chagas' disease,
however, is poorly understood. One possible approach to
this question involves the identification and characterization
of parasite antigens and analysis of the immune responses
that they elicit in the mammalian host.
We have used DNA cloning techniques to identify and
characterize T. cruzi antigens of clinical interest. We de-
scribe the isolation and characterization of a recombinant
clone that expresses an immunodominant T. cruzi antigen
which is specifically recognized by antibodies from human
chagasic patients. The recombinant antigen shares common
antigenic determinants with a high-molecular-weight cyto-
skeletal protein associated with the flagellum. Our results
suggest that this antigen contains immunodominant epitopes
present in all of the developmental stages of the parasite
which could be used to develop diagnostic procedures.
MATERIALS AND METHODS
Parasites. T. cruzi was grown in liver infusion tryptose
liquid medium supplemented with 10% heat-inactivated fetal
calf serum at 28°C without shaking. Metacyclic trypomasti-
gotes were isolated from cultures at the late stationary
growth phase by chromatography on DEAE-cellulose col-
umns. Cell culture trypomastigotes and amastigotes were
obtained from infected monolayers of Vero and HeLa cells.
Amastigotes were also obtained from spleens of infected
mice.
Library construction and screening. Nuclear DNA from
metacyclic trypomastigotes (G strain) was cloned in Xgtll as
described by Young et al. (22). In brief, random genomic
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fragments were generated by partial digestion with DNase I
and size fractionated on agarose gel (18). DNA fragments of
6.0 to 1.0 kilobases were eluted, ligated to EcoRI synthetic
linkers, and cloned into EcoRI sites of Xgtll. Part of the
library was directly used for screening without further puri-
fication.
Immunoscreening of the recombinant DNA expression
library was performed by the procedure of Ozaki et al. (13).
Human chagasic sera were preabsorbed with induced Xgtll
in Escherichia coli Y1090 bound to nitrocellulose filters for
12 h at 4°C. A library was plated out on Y1090 at a density of
2,000 plaques per 15-mm dish and grown at 42°C for 2 h.
Nitrocellulose filters were soaked in 10 mM isopropyl ,B-
D-thiogalactopyranoside in water, blotted dry, and placed on
the plates, and incubation was continued for 2 h at 37°C.
The filters were removed, washed, and blocked in PBSM
(10 mM sodium phosphate [pH 7.5], 150 mM NaCl, 5%
defatted powdered milk) and probed with a 1:100 dilution of
human chagasic sera overnight at 4°C. Filters were washed
three times in an excess of PBSM and assayed for bound
antibodies, using 1251-labeled protein A and rabbit anti-
human immunoglobulin coupled to peroxidase.
Phage dot blot immunoassay. Individual recombinant
phages were subjected to a number of screenings with
several serum samples, using the phage plaque immunoas-
say. Phages of positive clones as well as nonrecombinant
Agtll were individually dotted in 1 ,uI of phage buffer (100
mM NaCI, 50 mM Tris [pH 7.5], 5 mM MgSO4, 0.01%
gelatin) containing 100 PFU onto a lawn of E. coli Y1090
cells growing on LB (Luria-Bertani medium) agar plates.
Cultures were grown and probed as described above for
library screening.
Antibody selection (plaque antibody selection). Recombi-
nant phages were plated at a density of 105 PFU/150-mm LB
agar plate and incubated at 42°C for 2 to 3 h. A filter of
nitrocellulose soaked in 10 mM isopropyl 3-D-thiogalactopy-
ranoside was layered on a petri dish for 2 h at 37°C, flipped
over on the same plate, and incubated for another 2 h. The
filters were incubated with serum diluted 1:50. After wash-
ing, bound antibodies were eluted with 5 ml of 0.2 M glycine,
pH 2.8, and neutralized with Tris base (13). These antibodies
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were dialyzed against 10 mM Tris hydrochloride, pH 7.5,
and subsequently used to probe immunoblots of parasite
protein extract or in electron microscopy immunolocaliza-
tion studies.
SDS-PAGE and immunoblotting. Sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) was per-
formed with parasites and bacterial lysates in 7.5 or 5.0%
gels as described previously (8). Immunoblotting was carried
out by the method of Towbin et al. (20). Bound antibodies
were revealed with rabbit anti-human immunoglobulin cou-
pled to peroxidase. Protein molecular weight markers (mo-
lecular weight in parentheses) were from Sigma Chemical
Co.: myosin heavy chain (200,000), P-galactosidase
(116,000), phosphorylase b (92,500), bovine serum albumin
(67,500), ovalbumin (43,000), carbonic anhydrase (30,000),
and lysozyme (14,300). Mouse erythrocytes were used as a
source of spectrins (molecular weights, 240,000 and
220,000).
Antisera. Human chronic chagasic sera were obtained
from patients with chronic Chagas' disease diagnosed by
serological and clinical symptoms. Serological analyses were
performed by indirect immunofluorescence, indirect hemag-
glutination, and complement fixation tests. Pools of chronic
chagasic sera were obtained from blood transfusion centers
at Sao Paulo, Brazil. Antibodies against the recombinant
antigen were raised in BALB/c mice by injecting the partially
purified recombinant antigen. Sera also were obtained from
patients with other parasitic diseases diagnosed by serolog-
ical and clinical symptoms. Indirect immunofluorescence
and hemagglutination tests were used to detect specific
antibodies in the sera from these patients. Sera from humans
infected with T. rangeli were also analyzed by enzyme-
linked immunosorbent assay, using epimastigote antigens
from this parasite. These sera were kindly provided by
Felipe Guhl, Universidad de los Andes, Bogota, Colombia.
Immunofluorescence and immunoelectron microscopy. Im-
munofluorescence of extracellular forms was carried out
with formaldehyde-fixed parasites. Isolation of parasite cy-
toskeletons and immunofluorescence labeling were done as
described previously (12). For intracellular staining of para-
sites, HeLa cells grown on glass cover slips were infected
with T. cruzi metacyclic tryptomastigotes. At 72 to 96 h
postinfection, cover slips were washed five times with 10
mM sodium phosphate (pH 7.5)-150 mM NaCl (PBS) and
fixed with 3.5% formaldehyde-PBS for 30 min; excess
aldehyde was quenched with a 15-min incubation in 50 mM
NH4Cl-PBS, and samples were soaked in PBS containing
0.25% gelatin-0.01% saponin to prevent nonspecific binding
and permeabilize the cells. Cover slips were then inverted
onto 30-pi drops of antibody for 1 h, rinsed in PBS, and
exposed to 1:40 dilutions of fluorescein isothiocyanate-
anti-human immunoglobulin G for 30 min. After a rinse with
PBS, cover slips were mounted in 0.1 M glycine (pH
9.6)-90% glycerol. Samples were examined on a Leitz La-
borlux D epifluorescence microscope with x40 and x100
objectives. Photographs were taken on 400-ASA Ilford HP-5
films, subsequently developed for 18 min with Microdol-X
(Eastman Kodak Co.).
To localize the parasite antigen in the electron micro-
scope, cytoskeletons fixed with 4% para-formaldehyde-
0.1% glutaraldehyde in 0.1 M sodium cacodylate, pH 7.4,
were adsorbed onto poly-L-lysine-coated Parlodion grids;
after 15 min, the grids were soaked in electron microscopy
buffer (0.1 M Tris hydrochloride [pH 7.4], 0.1% gelatin, 1%
ovalbumin, 0.5% Tween 20 [2]) for 1 h. Samples were then
incubated with affinity-selected human anti-H49 antibodies
diluted 1:1 in electron microscopy buffer for another hour.
Unbound antibodies were removed by rinsing with running
distilled water for 1 min. Grids were then soaked in electron
microscopy buffer in a 1:40 dilution of protein A coupled to
10-nm colloidal gold particles (a kind gift from Paul Webster,
ILRAD, Nairobi, Kenya) and incubated for 1 h. After being
rinsed as above, samples were stained with 1% aqueous
uranyl acetate, air dried, and examined on a JEOL 100 CXII
electron microscope operated at 80 kV.
Southern and Northern hybridizations. Southern blots
were performed as described earlier (10). DNA samples
were electrophoresed in 0.7% (wt/vol) agarose gels and
transferred to nitrocellulose. Prehybridization was per-
formed at 45°C for 4 h in hybridization buffer (5 x SSC [lx
SSC is 0.15 M NaCl plus 0.015 M sodium citrate, pH 7.5], 5x
Denhardt solution, 50% formamide, 0.1% SDS, 100 ,ug of
sonicated herring sperm DNA per ml, 50 ptg of yeast tRNA
per ml). The hybridization was carried out at 45°C for 24 h
with 5 to 10 ml of fresh hybridization buffer per filter
supplemented with 2 x 106 cpm of the probe per ml.
Posthybridizations washes were carried out at 60°C two
times for 30 min each in 2 x SSC, twice for 30 min each in 1x
SSC, and for 60 min in 0.l x SSC. For Northern (RNA) blot
analysis, RNA was electrophoresed on formaldehyde-aga-
rose gels and transferred to nitrocellulose. Hybridizations
and washings were carried out as described for Southern
blotting.
RESULTS
Clone H49 encodes a T. cruzi dominant immunogen in
humans. A T. cruzi genomic library was constructed in the
expression vector Xgtll, using nuclear DNA from metacy-
clic trypomastigotes. About 50,000 recombinant phages
were screened with a pool of human chronic chagasic sera.
Based on the signal intensity, one clone (designated clone
H49), of 30 recombinant phages identified, was chosen for
further characterization.
Clone H49 encodes a P-galactosidase fusion protein of
approximately 150 kilodaltons (kDa) (Fig. 1A, lanes 2 and 4).
Human chagasic sera reacted with the recombinant fusion
protein but not with lysates of nonrecombinant Xgtll-in-
fected bacteria (Fig. 1A, lanes 1 and 2). Antisera to 1-
galactosidase reacted with P-galactosidase (116 kDa) in
Xgtll lysates as well as with the fusion protein in H49 lysates
(150 kDa), indicating that the insert is located in the ,B-
galactosidase gene (Fig. 1A, lanes 3 and 4).
The reactivity of the recombinant antigen with human
chagasic antibodies was analyzed by immunoblot and phage
plaque immunoassay. A positive reaction was obtained with
up to 1:10,000 dilutions in immunoblot (Fig. 1B) and 1:5,000
dilutions in phage plaque immunoassay (Fig. 1C). This
shows that the reactivity of the recombinant antigen is not
significantly affected under the reducing conditions used in
the immunoblot.
The specificity of H49 recombinant antigen was tested
with sera from patients with the various clinical forms of
Chagas' disease and other parasitic diseases. The recombi-
nant antigen reacted with all 115 chronic chagasic sera tested
but not with sera from patients having other parasitic dis-
eases (Table 1). Most significantly, there was no reaction
with antibodies from patients with visceral or mucocutane-
ous leishmaniasis and T. rangeli infection (Table 1; Fig. 1C).
These results suggest that the presence of serum antibodies
to H49 antigen may be specifically associated with Chagas'
disease.
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FIG. 1. Reactivity of human chagasic serum to H49 recombinant antigen. (A) Lysates of induced nonrecombinant xgtll (lanes 1 and 3)
and clone H49 (lanes 2 and 4) were separated by SDS-PAGE, Western blotted, and probed with either human chronic chagasic sera (HCS)
(lanes 1 and 2) or mouse anti-p-galactosidase (anti-PGAL) (lanes 3 and 4). (B) Lysates of clone H49 were separated by SDS-PAGE (7.5%
polyacrylamide gel), Western blotted, and probed with a serial dilutions of human chagasic serum (HCS). (C) Phage plaque immunoassay.
Drops of clone H49 and nonrecombinant Xgtll were arrayed on plates and probed with serial dilutions of human chronic chagasic sera (HCS)
or human kala-azar sera (HKS). Immunocomplexes were revealed with either rabbit anti-human total immunoglobulin or anti-mouse total
immunoglobulin coupled to peroxidase.
Comparison of cloned gene product with T. cruzi native
polypeptides. Identification of T. cruzi native polypeptides
that share antigenic determinants with the product of clone
H49 was carried out with antibodies purified by the plaque
antibody selection technique (13). Human chagasic serum-
selected antibodies were used to identify the corresponding
parasite polypeptides on immunoblots of protein extracts of
metacyclic trypomastigotes, amastigotes, and epimastigotes
(Fig. 2). The selected antibodies strongly reacted with a T.
cruzi polypeptide of very large apparent size, 300 kDa (Fig.
2, lanes 1 to 3). In spite of the lack of adequate size markers
at this extreme molecular weight, the mobility of this antigen
was considerably greater than that of the 220- to 240-kDa
mouse spectrins. Antibodies purified from the same chagasic
serum on nonrecombinant Xgtll did not react with T. cruzi
TABLE 1. Reactivity of H49 recombinant antigen with antibodies
in serum samples from chagasic and nonchagasic patients
No. of serum No. of positiveDiagnosis smls results witha ples H49 antigen
Chronic Chagas' disease
Chronic cardiopathy 47 47
Digestive form 7 7
Cardiac and digestive forms 29 29





Tegumental leishmaniasis 8 0
Visceral leishmaniasis 29 0
T. rangeli infection 4 0
a Reactivity of the recombinant antigen was assayed by phage dot blot
immunoassay, using sera from chagasic patients (1:250 dilution) and from
those with other parasitic diseases (1:40 dilution). Chagasic sera represented
populations from the Brazilian states of Sào Paulo, Minas Gerais, GoiIs,
Bahia, and Paraiba.
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FIG. 2. Identification of native T. cruzi protein with selected
antibodies. Chagasic antibodies were purified on phages expressing
H49 antigen or nonrecombinant Agtll and used as probes in Western
blot (5.0% polyacrylamide gel) containing T. cruzi or Leishmania
extracts. Human chagasic antibodies immunopurified on clone H49
were reacted with metacyclic trypomastigotes (T), amastigotes (A),
and epimastigotes (E) from T. cruzi (lanes 1 to 3) and L. donovani
(Ld) and L. mexicana amazonensis (Lma) (lanes 7 and 8). Antibod-
ies immunopurified on nonrecombinant Xgtll were reacted with
metacyclic trypomastigotes, amastigotes, and epimastigotes (lanes 4
to 6). Immunocomplexes were revealed with rabbit anti-human total
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FIG. 3. Immunofluorescence localization of H49 antigen in T. cruzi. HeLa cells infected with T. cruzi were processed for immunofluo-
rescence with affinity-selected anti-H49 antibody after 48 (A and B) or 72 (C and D) h. (A and B) Fluorescence and corresponding
phase-contrast microscopy of intracellular amastigotes showing punctate pattern. (C and D) Anti-H49 labeling of intracellular trypomastigotes
with characteristic flagellar pattern. Magnification, x960.
antigens (Fig. 2, lanes 4 to 6). It is interesting to note that
human chagasic antibodies selected on clone H49 did not
recognize any antigen in Leishmania donovani and L. mex-
icana amazonensis extracts (Fig. 2, lanes 7 and 8). Anti-H49
antibodies also failed to react with Herpetomonas sam-
uelpessoai, Leptomonas samueli, and Crithidia deanei (data
not shown).
Cellular localization of H49 antigen. Human chagasic anti-
bodies immunoadsorbed to H49 fusion protein were used to
demonstrate and localize the H49 antigen on parasites by
indirect immunofluorescence and immunoelectron micros-
copy. By immunofluorescence, anti-H49 antibodies labeled
intracellular forms of T. cruzi. When infected HeLa cells
were treated with anti-H49, intracytoplasmatic amastigotes
reacted, yielding a punctate staining (Fig. 3A and B),
whereas trypomastigotes displayed a more organized fla-
gellar pattern (Fig. 3C and D). Anti-H49 antibodies also
stained isolated metacyclic trypomastigotes and cytoskele-
tons of both metacyclics and epimastigotes along the length
of the flagellum (not shown). A similar flagellar pattern was
also observed with metacyclic trypomastigotes from other T.
cruzi strains (Y, CL, Tulahuen, DM 28, and DM 30). There
was no reaction with L. mexicana amazonensis, T. brucei
brucei, or L. donovani (data not shown).
The immunofluorescence pattern obtained with formalde-
hyde-fixed parasites suggests that H49 antigen could be
associated with the T. cruzi cytoskeleton. To extend these
observations to the ultrastructural level, T. cruzi cytoskele-
tons were obtained by extracting cells in a microtubule-
stabilizing buffer containing Nonidet P-40 (10) and incubated
with anti-H49 antibodies followed by protein A coupled to
10-nm colloidal gold particles. In epimastigotes (Fig. 4A) and
trypomastigotes (metacyclic or culture derived; Fig. 4B and
C), anti-H49 antibodies gave a linear labeling along the
contact region between the flagellum and the cell body.
Furthermore, it is apparent that H49 antigen is a component
of neither the axoneme nor the flagellar paraxial structure
(see arrowheads in Fig. 4B and C). These localization studies
confirmed that H49 antigen is expressed in all developmental
stages of T. cruzi and is associated with the parasite's
cytoskeleton.
Northern and Southern blot analyses. Northern blot anal-
ysis showed the hybridization of clone H49 to an 8-kilobase
band present in trypomastigotes (Fig. 5A). A transcript of
this length is sufficient to encode a protein of 300 kDa.
Clone H49 was hybridized to T. cruzi genomic DNA
digested with EcoRI, BglII, AluI, and KpnI restriction
endonucleases. Single bands were identified in each lane
(Fig. 5B). We have also analyzed, by dot blot hybridization,
several T. cruzi strains (Y, CL, DM 28, DM 30, and
J. CLIN. MICROBIOL.
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FIG. 4. Immunoelectron microscopic localization of H49 antigen
on T. cruzi cytoskeletons. Cytoskeletons of T. cruzi epimastigotes
(A), metacyclic trypomastigotes (B), and culture-derived trypomas-
togotes (C) were labeled with affinity-selected anti-H49 antibodies
and bound immunoglobulin visualized with protein A coupled to
10-nm gold particles. Note the staining along the flagellum-body
attachment in all forms. Arrowheads in panel B indicate the ax-
oneme, and those in panel C show the paraxial structure. Magnifi-
cation, x27,000.
Tulahuen) and other trypanosomatids (L. mexicana amazo-
nensis, L. donovani, L. chagasi, samuelpessoai,
Crithidia luciliae termophila) looking for sequences homol-
ogous to clone H49. Clone H49 hybridized exclusively with
FIG. 5. Hybridization analyses of the H49 gene. (A) Northern
blot hybridization of total RNA from trypomastigotes with the H49
insert. T. cruzi rRNAs were used as size markers. (B) Southern blot
hybridization of T. cruzi genomic DNA with the H49 insert. The
restriction digests were EcoRI (lane 1), BglII (lane 2), AluI (lane 3),
and KpnI (lane 4). kb, Kilobases.
T. cruzi DNA, suggesting that it carries species-specific
sequences (data not shown).
DISCUSSION
We have shown that a T. cruzi DNA clone (H49) encodes
a recombinant protein that corresponds to a high-molecular-
veight protein associated with the parasite cytoskeleton.
H49 antigen is apparently a dominant immunogen of T.
cruzi. All chronic chagasic sera we tested for T. cruzi from
115 individuals living in endemic areas had sufficiently high
antibody titers to register in a phage plaque immunoassay. In
contrast to what has been found with other serologic meth-
ods (3, 4), we did not detect anti-H49 antibodies in samples
from patients with either mucocutaneous or visceral leish-
maniasis or T. rangeli infection. The presence of anti-H49
antibodies in chagasic patients from different regions of
Brazil suggests that an antigenic region of H49 protein is
conserved in many strains of T. cruzi. In fact, H49 antigen
and its gene were detected in several T. cruzi strains from
different geographical regions by indirect immunofluores-
cence and DNA hybridization. Taken together, these results
suggest that the presence of antibodies to H49 antigen may
be specifically associated with Chagas' disease; therefore,
the H49 recombinant antigen could be useful in the diagnosis
of this disease.
Immunoelectron microscopy showed that the H49 protein
is a structural component of the T. cruzi cytoskeleton. The
localization of H49 antigen in the contact region between the
flagellum and cell body strongly suggests that it is a compo-
nent of the desmosomelike flagellum-body attachment of
trypanosomes (21). The absence of reaction of anti-H49
antibodies with other trypanosomatids suggests that this
protein is a specific component of the T. cruzi flagellum-body
attachment and could be used as a species-specific molecular
marker for this structure.
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The presence of human antibodies against a T. cruzi
flagellum-associated protein is not an unexpected finding
since it has been shown that immunization of mice with
flagellar antigens induced high levels of specific antibodies
with little or no immunoaggressive effects (14, 16, 17).
Although the biologic role of H49 antigen remains to be
demonstrated, the availability of the recombinant antigen
and the corresponding human monospecific antibodies to
H49 antigen should make it possible to study the role of this
antigen in the pathogenic processes of Chagas' disease.
During the later stages of our work, several laboratories
reported the isolation of recombinant clones that encode T.
cruzi polypeptides containing tandemly arranged repeats (6,
7, 9). Lafaille et al. (9) demonstrated that one of these clones
encodes a T. cruzi flagellar protein. We are carrying out
experiments to determine the nucleotide sequence of the
H49 recombinant clone to compare it with the clones de-
scribed by these authors.
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